Delivery Order SPE2DB24D1205-SPE2DB25FCXLG
Award Date
6/5/25
Potential Completion Date
6/27/25
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,740.49 firm-fixed-price delivery order is for the procurement of 4,568,032,234 PROQUAD VIALS. The contract has an ultimate completion date of May 13, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency. The $80,593.20 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 13, 2025, with a completion date of June 4, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,686.44 firm fixed-price delivery order is for the supply of PROQUAD VIALS, with a completion date of July 7, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,654.33, is a delivery order for PROQUAD VIALS and has a completion date of February 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
The Defense Logistics Agency (DLA) awarded a $4,711.62 firm fixed-price delivery order to Amerisourcebergen Drug Corp for the supply of PROQUAD VIALS. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide these medical supplies to support various government agencies and healthcare programs, including military treatment facilities and veterans' hospitals. This delivery order is part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,012.70 firm fixed-price delivery order is for PROQUAD VIALS, with an ultimate completion date of April 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,247.58, is for the delivery of PROQUAD VIALS and has an ultimate completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $12,537.75 to AmerisourceBergen Drug Corp's Corporate Office division. The contract, which does not have a set-aside designation, is for the supply of PROQUAD VIALS and has an ultimate completion date of August 15, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been a significant supplier of pharmaceutical products and medical supplies to various federal agencies,...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The $3,320.38 firm fixed-price contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a performance period through June 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,575.60 firm fixed price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with...